Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT03190538)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT03190538 Sponsor: Humanity and Health Research Centre Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03190538 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 1 and 18 years old and have been diagnosed with NAFLD (a type of liver condition caused by fat buildup) confirmed by a biopsy (a small tissue sample taken from the liver)
Your alcohol consumption is below a certain level — less than 20g per day for boys and less than 10g per day for girls (confirm with trial site if you are unsure how this applies to you)

Who may not be able to join:

You have a viral liver infection, such as hepatitis B or hepatitis C
You have a condition called alpha-1 antitrypsin deficiency, which is an inherited disorder that can affect the liver
You have autoimmune hepatitis, which is when the body's immune system mistakenly attacks the liver
You have Wilson disease, which is an inherited condition that causes copper to build up in the liver
Your liver has been damaged by medication or other drugs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: George Lau, MD, PhD, Humanity and Health Medical Centre

Phone: 852-28613777

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03190538

Sponsor: Humanity and Health Research Centre

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 852-28613777

More information: https://clinicaltrials.gov/study/NCT03190538

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 1 and 18 years old and have been diagnosed with NAFLD (a type of liver condition caused by fat buildup) confirmed by a biopsy (a small tissue sample taken from the liver)
Your alcohol consumption is below a certain level — less than 20g per day for boys and less than 10g per day for girls (confirm with trial site if you are unsure how this applies to you)

Who may not be able to join:

You have a viral liver infection, such as hepatitis B or hepatitis C
You have a condition called alpha-1 antitrypsin deficiency, which is an inherited disorder that can affect the liver
You have autoimmune hepatitis, which is when the body's immune system mistakenly attacks the liver
You have Wilson disease, which is an inherited condition that causes copper to build up in the liver
Your liver has been damaged by medication or other drugs

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Humanity and Health Research Centre

Registry

ClinicalTrials.gov

Start date

1 May 2017

Est. completion

31 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Liver related death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov